Non-Cell Lung Cancer Therapeutics Companies Competing on Cost and Innovation Front to Remain Relevant
The global market for non-small cell lung cancer therapeutics has been witnessing robust growth, thanks to the new product launches in the recent years. The key players in the market are emphasizing on developing a strong pipeline of drugs to stay afloat in a highly competitive environment and gain higher shares in the revenue pie.
View full press release